ArticleJournal of neuro-oncology2012
Rituximab significantly improves complete response rate in patients with primary CNS lymphoma.
Tobias Birnbaum et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
41 papers cite it
this paperpooled ittrialcites it